57 related articles for article (PubMed ID: 3034420)
1. Oestradiol 16 alpha-hydroxylase: a risk marker for breast cancer.
Bradlow HL; Hershcopf RE; Fishman JF
Cancer Surv; 1986; 5(3):573-83. PubMed ID: 3034420
[TBL] [Abstract][Full Text] [Related]
2. Aryl hydrocarbon hydroxylase activity in mouse, rat, and human mammary tumors.
Mason ME; Okey AB
Cancer Res; 1981 Jul; 41(7):2778-82. PubMed ID: 6265068
[TBL] [Abstract][Full Text] [Related]
3. Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans.
Bradlow HL; Hershcopf RJ; Martucci CP; Fishman J
Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6295-9. PubMed ID: 2994069
[TBL] [Abstract][Full Text] [Related]
4. Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer.
Fishman J; Schneider J; Hershcope RJ; Bradlow HL
J Steroid Biochem; 1984 Apr; 20(4B):1077-81. PubMed ID: 6727352
[TBL] [Abstract][Full Text] [Related]
5. Estrogen metabolism and human papillomavirus-induced tumors of the larynx: chemo-prophylaxis with indole-3-carbinol.
Newfield L; Goldsmith A; Bradlow HL; Auborn K
Anticancer Res; 1993; 13(2):337-41. PubMed ID: 8390800
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk.
Osborne MP; Bradlow HL; Wong GY; Telang NT
J Natl Cancer Inst; 1993 Dec; 85(23):1917-20. PubMed ID: 8230281
[TBL] [Abstract][Full Text] [Related]
7. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
8. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
[TBL] [Abstract][Full Text] [Related]
9. Elevated estrogen 16 alpha-hydroxylase activity: is this a genotoxic or nongenotoxic biomarker in human breast cancer risk?
Nebert DW
J Natl Cancer Inst; 1993 Dec; 85(23):1888-91. PubMed ID: 8230275
[No Abstract] [Full Text] [Related]
10. Pathophysiologic considerations in the treatment of menopausal patients with oestrogens; the role of oestriol in the prevention of mammary carcinoma.
Lemon HM
Acta Endocrinol Suppl (Copenh); 1980; 233():17-27. PubMed ID: 6996403
[TBL] [Abstract][Full Text] [Related]
11. Hydrophobic side chain requirements for lauric acid and progesterone hydroxylation at amino acid 113 in cytochrome P450 2C2, a potential determinant of substrate specificity.
Straub P; Johnson EF; Kemper B
Arch Biochem Biophys; 1993 Nov; 306(2):521-7. PubMed ID: 8215458
[TBL] [Abstract][Full Text] [Related]
12. Life cycle of the murine mammary tumor virus, and a comparison with similar forms reported in human mammary carcinomas.
Dolowy WC
Tex Rep Biol Med; 1973; 31(4):745-53. PubMed ID: 4362650
[No Abstract] [Full Text] [Related]
13. Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer.
Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD
Clin Cancer Res; 2004 Jul; 10(13):4417-9. PubMed ID: 15240531
[TBL] [Abstract][Full Text] [Related]
14. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
16. 16 alpha-hydroxylation of estradiol: a possible risk marker for breast cancer.
Bradlow HL; Hershcopf R; Martucci C; Fishman J
Ann N Y Acad Sci; 1986; 464():138-51. PubMed ID: 3014947
[TBL] [Abstract][Full Text] [Related]
17. [Viruses and mammary cancer. A survey (author's transl)].
Ulvund MJ
Nord Vet Med; 1973 Sep; 25(9):451-63. PubMed ID: 4358520
[No Abstract] [Full Text] [Related]
18. Ring hydroxylation of [o-3H]methoxychlor as a probe for liver microsomal CYP2B activity: potential for in vivo CYP2B assay.
Stresser DM; Dehal SS; Kupfer D
Anal Biochem; 1996 Jan; 233(1):100-7. PubMed ID: 8789153
[TBL] [Abstract][Full Text] [Related]
19. [Diminished activity of testosterone-16-alpha hydroxylase in bovine liver microsomes].
Depelchin BO
Ann Rech Vet; 1984; 15(4):515-8. PubMed ID: 6529121
[TBL] [Abstract][Full Text] [Related]
20. Immunological studies on human breast carcinoma and mouse mammary tumors.
Priori ES; Anderson DE; Williams WC; Dmochowski L
J Natl Cancer Inst; 1972 Apr; 48(4):1131-5. PubMed ID: 4336878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
